Substituted pyrrolines as kinase inhibitors
US7232906B2 · kind B2 · utility
5Cited by
8References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 4, 2003 |
| Grant date | Jun 19, 2007 |
| Priority date | — |
| Expiry date | Mar 1, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to novel substituted pyrroline compounds useful as kinase or dual-kinase inhibitors, methods for producing such compounds and methods for treating or ameliorating a kinase or dual-kinase mediated disorder.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.